Sandusky, OH – November 25, 2020 – — PAO Group, Inc. (OTC: PAOG) today announced an interview of CEO Jim DiPrima on MoneyTV where Mr. DiPrima discusses the company’s progress in 2020 to include the latest updates on PAOG’s coming one for one dividend of PAOG stock to Puration, Inc. (OTC: PURA) shareholders in conjunction with PAOG’s recent acquisition of PURA’s cannabis cultivation business.
PAOG made two strategic acquisitions this year transitioning the company into the cannabis neurocritical and pharmaceutical markets. PAOG has recently executed an agreement with a Contract Research Organization (CRO) to advance the company’s hemp derived CBD extract to treat Chronic Obstructive Pulmonary Disorder (COPD) toward an FDA approval. PAOG is also close to executing a neurocritical development agreement. In addition to the interview published today, the company anticipates issuing substantial updates on the pharmaceutical and neurocritical developments next week.
MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures. MoneyTV is seen in over 200 million TV households in more than 75 countries.
Free information packages from the featured companies can be requested by sending an email to firstname.lastname@example.org.
The television program can also be viewed online immediately at www.moneytv.net.
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.